70 related articles for article (PubMed ID: 14596503)
1. Costs of radiotherapy.
Norlund A;
Acta Oncol; 2003; 42(5-6):411-5. PubMed ID: 14596503
[TBL] [Abstract][Full Text] [Related]
2. Patient positioning in the proton radiotherapy era.
Devicienti S; Strigari L; D'Andrea M; Benassi M; Dimiccoli V; Portaluri M
J Exp Clin Cancer Res; 2010 May; 29(1):47. PubMed ID: 20465816
[TBL] [Abstract][Full Text] [Related]
3. [Health-economic aspects of radiotherapy].
Vandemaele M; Lievens Y
Rev Med Liege; 2024 May; 79(S1):117-122. PubMed ID: 38778659
[TBL] [Abstract][Full Text] [Related]
4. Global Radiotherapy: Current Status and Future Directions-White Paper.
Abdel-Wahab M; Gondhowiardjo SS; Rosa AA; Lievens Y; El-Haj N; Polo Rubio JA; Prajogi GB; Helgadottir H; Zubizarreta E; Meghzifene A; Ashraf V; Hahn S; Williams T; Gospodarowicz M
JCO Glob Oncol; 2021 Jun; 7():827-842. PubMed ID: 34101482
[TBL] [Abstract][Full Text] [Related]
5. Accurate method for evaluating the duration of the entire radiotherapy process.
Guo C; Huang P; Li Y; Dai J
J Appl Clin Med Phys; 2020 Sep; 21(9):252-258. PubMed ID: 32710490
[TBL] [Abstract][Full Text] [Related]
6. Number of radiotherapy treatment machines in the population and cancer mortality: an ecological study.
Medenwald D; Vordermark D; Dietzel CT
Clin Epidemiol; 2018; 10():1249-1273. PubMed ID: 30288122
[TBL] [Abstract][Full Text] [Related]
7. Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?
Thompson MK; Poortmans P; Chalmers AJ; Faivre-Finn C; Hall E; Huddart RA; Lievens Y; Sebag-Montefiore D; Coles CE
Br J Cancer; 2018 Aug; 119(4):389-407. PubMed ID: 30061587
[TBL] [Abstract][Full Text] [Related]
8. Personal perspectives on the evolution of radiation therapy and future outlook for SRS.
Paddick I
J Radiosurg SBRT; 2018; 5(2):87-88. PubMed ID: 29657888
[No Abstract] [Full Text] [Related]
9. The evolution of brachytherapy for prostate cancer.
Zaorsky NG; Davis BJ; Nguyen PL; Showalter TN; Hoskin PJ; Yoshioka Y; Morton GC; Horwitz EM
Nat Rev Urol; 2017 Jun; 14(7):415-439. PubMed ID: 28664931
[TBL] [Abstract][Full Text] [Related]
10. The changes of radiotherapy in Lithuania: infrastructure, utilization rate, and cost.
Mineikytė R; Janulionis E; Atkočius V; Jaruševičius L; Plieskienė A; Gečas J
Acta Med Litu; 2016; 23(1):17-23. PubMed ID: 28356788
[No Abstract] [Full Text] [Related]
11. A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer.
Avkshtol V; Dong Y; Hayes SB; Hallman MA; Price RA; Sobczak ML; Horwitz EM; Zaorsky NG
Res Rep Urol; 2016; 8():145-58. PubMed ID: 27574585
[TBL] [Abstract][Full Text] [Related]
12. Demand for radiotherapy in Spain.
Rodríguez A; Borrás JM; López-Torrecilla J; Algara M; Palacios-Eito A; Gómez-Caamaño A; Olay L; Lara PC
Clin Transl Oncol; 2017 Feb; 19(2):204-210. PubMed ID: 27492014
[TBL] [Abstract][Full Text] [Related]
13. Direct costs of radiotherapy for rectal cancer: a microcosting study.
Hanly P; Céilleachair AÓ; Skally M; O'Neill C; Sharp L
BMC Health Serv Res; 2015 May; 15():184. PubMed ID: 25934169
[TBL] [Abstract][Full Text] [Related]
14. Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer Stenting): study protocol for a randomized controlled trial.
Adamson D; Blazeby J; Nelson A; Hurt C; Nixon L; Fitzgibbon J; Crosby T; Staffurth J; Evans M; Kelly NH; Cohen D; Griffiths G; Byrne A
Trials; 2014 Oct; 15():402. PubMed ID: 25336193
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the attendance of medical staff and room occupancy during palliative radiotherapy.
Adamietz IA; Micke O; Popp W; Sack H
Strahlenther Onkol; 2014 Sep; 190(9):781-5. PubMed ID: 24820198
[TBL] [Abstract][Full Text] [Related]
16. Protection of quality and innovation in radiation oncology: the prospective multicenter trial the German Society of Radiation Oncology (DEGRO-QUIRO study). Evaluation of time, attendance of medical staff, and resources during radiotherapy with IMRT.
Vorwerk H; Zink K; Schiller R; Budach V; Böhmer D; Kampfer S; Popp W; Sack H; Engenhart-Cabillic R
Strahlenther Onkol; 2014 May; 190(5):433-43. PubMed ID: 24595416
[TBL] [Abstract][Full Text] [Related]
17. Evolution of advanced technologies in prostate cancer radiotherapy.
Zaorsky NG; Harrison AS; Trabulsi EJ; Gomella LG; Showalter TN; Hurwitz MD; Dicker AP; Den RB
Nat Rev Urol; 2013 Oct; 10(10):565-79. PubMed ID: 24018567
[TBL] [Abstract][Full Text] [Related]
18. Systematic review of hypofractionated radiation therapy for prostate cancer.
Zaorsky NG; Ohri N; Showalter TN; Dicker AP; Den RB
Cancer Treat Rev; 2013 Nov; 39(7):728-36. PubMed ID: 23453861
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of time, attendance of medical staff, and resources during radiotherapy for breast cancer patients. The DEGRO-QUIRO trial.
Blank E; Willich N; Fietkau R; Popp W; Schaller-Steiner J; Sack H; Wenz F
Strahlenther Onkol; 2012 Feb; 188(2):113-9. PubMed ID: 22241435
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of time, attendance of medical staff, and resources during radiotherapy for head and neck cancer patients: the DEGRO-QUIRO trial.
Budach W; Bölke E; Fietkau R; Buchali A; Wendt TG; Popp W; Matuschek C; Sack H
Strahlenther Onkol; 2011 Aug; 187(8):449-60. PubMed ID: 21786109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
